耳鼻咽喉科・頭頸部外科94巻1号

2022年01月発行

特集 新たに薬事承認・保険収載された薬剤・医療資材・治療法ガイド

《頭頸部》

ホウ素中性子捕捉療法（BNCT）を用いた頭頸部癌治療

著者： 廣瀬勝己¹

所属機関： ¹南東北BNCT研究センター

ページ範囲：P.66 - P.72

文献概要

POINT

●ホウ素中性子捕捉療法（BNCT）は，ホウ素と中性子の反応によって生じるα線と放出リチウム核のエネルギーを利用したミクロレベルの局所的な重粒子線治療である。

●局所再発の扁平上皮癌に対する初期治療効果は，完全奏効率で5割程度である。

●局所再発をきたした切除不能な患者では，深部への進展がない早い段階で本治療を検討することが望ましい。

参考文献

1）Coderre JA, et al：The radiation biology of boron neutron capture therapy. Radiat Res 151：1-18, 1999

2）Kato I, et al：Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies. Appl Radiat Isot 67（7-8 Suppl）：S37-S42, 2009

3）Barth RF, et al：Boron neutron capture therapy of cancer：current status and future prospects. Clin Cancer Res 11：3987-4002, 2005

4）Nakagawa Y, et al：Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams. J Neurooncol 62：87-99, 2003

5）Diaz AZ：Assessment of the results from the phase Ⅰ/Ⅱ boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view. J Neurooncol 62：101-109, 2003

6）Busse PM, et al：A critical examination of the results from the Harvard-MIT NCT program phase Ⅰ clinical trial of neutron capture therapy for intracranial disease. J Neurooncol 62：111-121, 2003

7）Joensuu H, et al：Boron neutron capture therapy of brain tumors：clinical trials at the finnish facility using boronophenylalanine. J Neurooncol 62：123-134, 2003

8）Kato I, et al：Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 61：1069-1073, 2003

9）Kankaanranta L, et al：Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int J Radiat Oncol Biol Phys 69：475-482, 2007

10）Kankaanranta L, et al：Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer：final analysis of a phase Ⅰ/Ⅱ trial. Int J Radiat Oncol Biol Phys 82：e67-e75, 2012

11）Wang LW, et al：Fractionated boron neutron capture therapy in locally recurrent head and neck cancer：a prospective phase Ⅰ/Ⅱ trial. Int J Radiat Oncol Biol Phys 95：396-403, 2016

B）for recurrent or locally advanced head and neck cancer（JHN002）：an open-label phase Ⅱ trial. Radiother Oncol 155：182-187, 2021

13）Spencer SA, et al：RTOG 96-10：reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 51：1299-1304, 2001

14）Langer CJ, et al：Phase Ⅱ study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck：results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 25：4800-4805, 2007

15）Langendijk JA, et al：A phase Ⅱ study of primary reirradiation in squamous cell carcinoma of head and neck. Radiother Oncol 78：306-312, 2006

16）Berger B, et al：Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma：update of a single-center prospective phase Ⅱ protocol. Strahlenther Onkol 186：255-261, 2010

17）Vormittag L, et al：Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase Ⅱ trial. Strahlenther Onkol 188：235-242, 2012

18）Vargo JA, et al：A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 91：480-488, 2015